Costs and neonatal outcomes after insulin aspart compared with human insulin in pregnant women with type I diabetes

被引：0
|
作者：
Lioxd, A. C. [1 ]
Twena, N. [2 ]
Townsend, C. [3 ]
Holman, A. J. [1 ]
机构：
[1] Fourth Hurdle Consulting, London, England
[2] Novo Nordisk Ltd, Crawley, W Sussex, England
[3] Novo Nordisk AS, Virum, Denmark
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A262 / A262
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK
    Lloyd, A.
    Townsend, C.
    Munro, V.
    Twena, N.
    Nielsen, S.
    Holman, A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 599 - 605
  • [2] No increase in insulin antibodies and no clear evidence of transfer of insulin aspart across the placenta in pregnant women with type I diabetes
    McCance, David
    Damm, Peter
    Mathiesen, Elisabeth
    Kaaja, Risto
    Dunne, Fidelma
    Hod, Moshe
    Jensen, Linda
    Mersebach, Henriette
    [J]. DIABETES, 2007, 56 : A22 - A22
  • [3] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    [J]. DIABETES, 2003, 52 : A567 - A567
  • [4] Insulin pump compared to injected insulin in pregnant women with type 1 diabetes
    Cheng, Yvonne
    Block-Kurbisch, Ingrid
    Inturrisi, Maribeth
    Ustinov, Alla
    Caughey, Aaron
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S125 - S125
  • [5] Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
    D. R. McCance
    P. Damm
    E. R. Mathiesen
    M. Hod
    R. Kaaja
    F. Dunne
    L. E. Jensen
    H. Mersebach
    [J]. Diabetologia, 2008, 51 : 2141 - 2143
  • [6] Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
    McCance, D. R.
    Damm, P.
    Mathiesen, E. R.
    Hod, M.
    Kaaja, R.
    Dunne, F.
    Jensen, L. E.
    Mersebach, H.
    [J]. DIABETOLOGIA, 2008, 51 (11) : 2141 - 2143
  • [7] Use of rapid-acting insulin aspart reduces costs and cardiovascular complications in type 2 diabetes when compared with human insulin
    Pollock, R. F.
    Valentine, W. J.
    Thomsen, T. L.
    Nishimura, H.
    [J]. DIABETOLOGIA, 2009, 52 : S349 - S350
  • [8] PHARMACOKINETICS OF INSULIN ASPART IN PREGNANT WOMEN WITH TYPE 1 DIABETES: EVERY DAY IS DIFFERENT
    Murphy, H. R.
    Goudie, R. J. B.
    Lunn, D.
    Hovorka, R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A91 - A91
  • [9] Pharmacokinetics of Insulin Aspart in Pregnant Women With Type 1 Diabetes: Every Day Is Different
    Goudie, Robert J. B.
    Lunn, David
    Hovorka, Roman
    Murphy, Helen R.
    [J]. DIABETES CARE, 2014, 37 (06) : E121 - E122
  • [10] Comparison of Glibenclamide and Insulin on Neonatal Outcomes in Pregnant Women with Gestational Diabetes
    Behrashi, Mitra
    Samimi, Mansooreh
    Ghasemi, Tayyebeh
    Saberi, Farzaneh
    Atoof, Fatemeh
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2016, 7
12345